![](https://webarchive.library.unt.edu/eot2008/20090509155527im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090509155527im_/http://www.cancer.gov/images/spacer.gif)
meloxicam An oxicam derivative and a non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory, antipyretic and analgesic activities. Unlike traditional nonselective NSAIDs, meloxicam preferentially inhibits the activity of cyclo-oxygenase II (COX-II), resulting in a decreased conversion of arachidonic acid into prostaglandin precursors. The resulting decrease in prostaglandin synthesis is responsible for the therapeutic effects of meloxicam. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
![](https://webarchive.library.unt.edu/eot2008/20090509155527im_/http://www.cancer.gov/images/spacer.gif)
US brand names: | ![](https://webarchive.library.unt.edu/eot2008/20090509155527im_/http://www.cancer.gov/images/spacer.gif) | Mobec Mobic Mobicox Movalis Movatec | | ![](https://webarchive.library.unt.edu/eot2008/20090509155527im_/http://www.cancer.gov/images/spacer.gif) | Chemical structure name: | ![](https://webarchive.library.unt.edu/eot2008/20090509155527im_/http://www.cancer.gov/images/spacer.gif) | 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide | | ![](https://webarchive.library.unt.edu/eot2008/20090509155527im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090509155527im_/http://www.cancer.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090509155527im_/http://www.cancer.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090509155527im_/http://www.cancer.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20090509155527im_/http://www.cancer.gov/images/spacer.gif) |